Articles related to PEER-TO-PEER

There is much we don’t know because of weak surveillance methods. For informed decisions, medicine needs a better understanding of what is happening and what is working at any given time. Since even with 100% vaccination, the virus will at minimum continue in circulation, a key goal is to focus on those who are most at risk for severe disease and learn how to strengthen their immunity.

Marc R. Bloomenstein, OD, FAAO examines the status of various ophthalmic medications in the first video of 2023, including preservative-free latanoprost for IOP reduction (IYUZEH, Thea Pharma), MydCombi (Eyenovia) for in-office pupil dilatation, and others.

Beliefs and Attitudes Towards Cancer Prevention Among Anti-vaxxers, Flat Earthers, and Reptilian Conspiracists: Online Cross Sectional Survey The fact that more than half of the 1,494 survey respondents agreed that “It seems like everything causes cancer” underscores the challenge society faces in separating real causes from mythological ones as a result of widespread information. Contrary to their counterparts, those who believed in conspiracies, disapproved of the COVID-19 vaccination, or supported alternative medicine were more likely to support the fictitious causes of cancer while being less likely to support the real causes of cancer. These findings imply a clear link between online disinformation and ensuing unhealthy choices, which may account for an additional portion of cancer that is preventable.

Controversies about contact lenses are ongoing, and the American Optometric Association Contact Lens and Cornea Section leadership is once again thrilled to present a fresh series on this subject in this yearly piece for Contact Lens Spectrum. These debates concern the following topics: On-label vs. off-label myopia management treatments Do we overprescribe scleral lenses? Should all contact lens wearers be fitted with daily disposable lenses?

What’s expected for medical practice in 2023? Worker shortages will persist, with the biggest gaps being nonprofessional staff. Shortages will drive competition to attract even workers with entry-level skills, which will generate wage increases and turmoil as workers move to take advantage of better offers. Wage and goods inflation will continue to press on profits. The move to value-based fee structures will increase. And there will likely be a focus on better integrating merged organizations instead of the prior frenetic acquisition land grab.

In an analysis of electronic messages from patients, women physicians, DOs, and PCPs are twice as likely as other physicians to be referred to by their first name instead of as “doctor.” Is it acceptable? Is it good for the relationship? What are the best responses for institutions and individual practitioners?